International Brazilian Journal of Urology, published by the Brazilian Society of Urology, is a distinguished open-access journal that has been contributing to the field of urology since 2003. This journal plays a vital role in disseminating high-quality research and advancements in various aspects of urological science and medicine, targeting an international audience of researchers, practitioners, and students. With an impressive ranking in the 2023 Scopus metrics, securing Q2 status in both Medicine (Miscellaneous) and Urology, it stands as a significant resource for emerging trends and discoveries in these areas. The journal’s commitment to accessibility, with open access since its inception, ensures that valuable findings are readily available to the global medical community. Situated in Rio de Janeiro, Brazil, the International Brazilian Journal of Urology not only enhances academic discourse but also fosters collaboration across borders and specialties, making it a pivotal platform for advancing urological research.

European Urology Oncology is a premier academic journal dedicated to advancing the field of urological oncology through innovative research and interdisciplinary collaboration. Published by Elsevier and based in the Netherlands, this journal runs on the principles of providing high-quality, peer-reviewed content that meets the evolving needs of professionals in medicine, surgery, and oncology. With an impressive 2023 categorization in the Q1 quartiles across multiple disciplines including Medicine (Miscellaneous), Oncology, and Urology, the journal demonstrates its pivotal role in disseminating essential findings that enhance clinical practices. The E-ISSN of this journal is 2588-9311, ensuring accessibility to groundbreaking articles that influence treatment methodologies and patient outcomes. Researchers and professionals relying on the latest evidence in urology and oncology will find this journal essential for keeping abreast of cutting-edge developments and clinical insights that shape the future of healthcare.

BJU International is a prestigious academic journal specializing in the field of Urology, published by WILEY, one of the leading publishers in scientific literature. With an impressive impact factor and recognized as a Q1 journal in Urology for 2023, it ranks #7 out of 120 in the Scopus Medicine _ Urology category, placing it in the 94th percentile among its peers. Established in 1929 and with converged years from 1994 to 2024, BJU International provides a platform for groundbreaking research, clinical studies, and advancements in urological science. The journal is accessible in both print and online formats, catering to a global audience dedicated to enhancing urological practice and research. By fostering interdisciplinary dialogue and disseminating high-quality studies, BJU International plays a crucial role in advancing knowledge and improving patient care in the field of urology.

Urological Science, published by Lippincott Williams & Wilkins, is a prominent open-access journal that has been a vital resource for the Urology field since its establishment in 2010. With a focus on innovative research and advancements in urological science, the journal aims to disseminate significant findings and encourage dialogue among physicians, researchers, and healthcare professionals worldwide. The journal has achieved a commendable Q3 rank within its category according to the latest quartiles released in 2023 and holds a Scopus rank of #80 out of 120 in the Medicine Urology field, placing it in the 33rd percentile. By providing an open-access platform, Urological Science ensures that vital research is easily accessible to a global audience, supporting the ongoing advancements in urological healthcare and education. As the landscape of urology evolves, this journal remains an essential vehicle for sharing knowledge and improving patient outcomes, making it an invaluable resource for anyone invested in the future of urological science.

Research and Reports in Urology, published by DOVE MEDICAL PRESS LTD, is a premier journal dedicated to the dissemination of cutting-edge research and clinical advancements in the field of urology. With an impressive impact factor and a recognized status as Q2 within the urology category, this journal offers a vital platform for researchers, practitioners, and students eager to engage with the latest findings and methodologies. Since its inception in 2009, the journal has embraced an Open Access model, ensuring that critical research is freely available to the global community, thereby fostering collaboration and innovation in urological science. Based in New Zealand, it operates within a robust international framework, allowing for a diverse range of contributions that address pressing issues in urology and enhance professional knowledge. Researchers are encouraged to submit their work and become part of this influential discourse, as the journal continues to navigate the rapidly evolving landscape of urological health from 2012 to 2024 and beyond.

Urology Annals, published by Wolters Kluwer Medknow Publications, is a premier open-access journal dedicated to advancing the field of urology through high-quality research and clinical insights. Established in India in 2009, this journal serves as a vital platform for communication among urologists, researchers, and medical professionals, aiming to enhance understanding and innovation in urological sciences. With an ISSN of 0974-7796 and an E-ISSN of 0974-7834, the journal offers unrestricted access to its content, fostering knowledge dissemination and collaboration across the global medical community. Currently ranked in the Q3 category within urology and holding a Scopus rank of #79/120, Urology Annals showcases significant contributions that align with its mission to publish original research, reviews, and case reports that address contemporary challenges in urology. The journal's ongoing commitment to remaining a leading resource in the field is reflected through its convergence of years from 2010 to 2024, ensuring that it stays at the forefront of the latest urological advancements.

Turkish Journal of Urology, published by AVES, is a distinguished academic journal dedicated to the field of urology. As an open-access journal since 2022, it aims to disseminate high-quality research findings, clinical studies, and reviews that contribute to the advancement of urological science and practice. With a notable presence in the academic community, the journal currently holds a Scopus rank of #59 out of 107 in the Medicine _ Urology category, placing it in the 45th percentile. This positions the Turkish Journal of Urology as a vital resource for researchers, healthcare professionals, and students seeking to stay informed on the latest developments and innovations in urology. Publishing from its base in Istanbul, Turkiye, the journal emphasizes accessibility and visibility, making it a powerful platform for scholarly communication in an increasingly globalized field.

BMC Urology is a premier open-access journal dedicated to advancing research in the field of urology, reproductive medicine, and miscellaneous aspects of medicine. Published by BMC since 2001 and based in the United Kingdom, this journal provides a platform for researchers, clinicians, and students to disseminate their findings and explore the latest innovations and advancements within these vital fields. With a notable impact factor and categorization in the Q2 quartile for various categories of medicine, BMC Urology stands as a reputable source, ranking 51st out of 120 in Urology and 44th out of 90 in Reproductive Medicine according to Scopus metrics. The journal fosters knowledge sharing through its open-access model, ensuring that research is accessible to all. As it converges from 2001 to 2024, BMC Urology continues to play a crucial role in shaping the landscape of urological research and providing invaluable insights into clinical practices.

Welcome to the Scandinavian Journal of Urology, a dynamic platform dedicated to advancing the fields of urology and nephrology. Published by Medical Journal Sweden AB and located in the United Kingdom, this esteemed journal features open access options that enhance the accessibility of cutting-edge research to a global audience. With an impressive impact factor and a respectable position in Scopus rankings—#55/120 in Urology and #45/81 in Nephrology—the journal occupies a vital niche for researchers, clinicians, and students eager to share and engage with pioneering studies from 2013 to 2024. As part of the Q2 quartile in both urology and nephrology categories, the Scandinavian Journal of Urology plays a crucial role in informing and shaping contemporary clinical practices and research directions. Join us in exploring the latest developments and evidence-based findings in these essential areas of medical science.

UROLOGY is a prestigious journal published by Elsevier Science Inc, renowned for disseminating high-quality research and reviews in the field of urology. With an ISSN of 0090-4295 and E-ISSN 1527-9995, this journal has been a trusted resource since its inception in 1973 and continues to provide insights into the latest advancements and clinical practices in urology, maintaining a category quartile of Q2 as of 2023. The journal ranks 50th out of 120 in the Scopus metrics for Medicine - Urology, placing it in the 58th percentile, which underscores its influence and relevance in the academic community. Although it is not structured as an open access journal, it offers a wealth of knowledge vital for researchers, healthcare professionals, and students alike, enabling them to stay abreast of evolving treatments and innovations in the field. As we move towards 2024, UROLOGY remains committed to advancing research and enhancing practices in urological care, fostering a collaborative environment among its readership.